In the preceding three months, 16 analysts have released ratings for Paycor HCM (NASDAQ:PYCR), presenting a wide array of perspectives from bullish to bearish. The table below provides a concise ...
Paycor HCM, Inc. (PYCR) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.11 per share a year ago.
Paycor HCM, Inc. PYCR is scheduled to report second-quarter fiscal 2025 results on Feb. 5, after market close. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. PYCR expects ...
NASDAQ PYCR opened at $22.14 on Friday. The stock’s 50-day simple moving average is $20.68 and its two-hundred day simple moving average is $16.64. Paycor HCM has a twelve month low of $10.92 ...
Hosted on MSN29d
Analyst lowers Paycor HCM stock outlook, citing capped gains from Paychex acquisitionThe downgrade follows the announcement on January 7, 2025, that Paychex, Inc. (PAYX) will acquire Paycor HCM in an all-cash transaction valued at $22.50 per share. As of the market close on ...
Shares of Paycor HCM stock opened at $22.18 on Wednesday. The company has a market capitalization of $3.98 billion, a price-to-earnings ratio of -85.31, a PEG ratio of 4.17 and a beta of 0.50. The ...
Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can ...
Baird downgraded Paycor HCM (PYCR) to Neutral from Outperform with a price target of $22.50, down from $28. The firm now believes is highly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results